# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641489-24-000023
Filing Date
2024-04-25
Accepted
2024-04-25 16:23:13
Documents
22
Period of Report
2024-06-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | vtvt-20240425.htm iXBRL | DEF 14A | 846221
6 | GRAHPIC | vtvt-20240425_g1.jpg | GRAPHIC | 684980
7 | GRAHPIC | vtvt-20240425_g2.jpg | GRAPHIC | 120640
8 | GRAHPIC | vtvt-20240425_g3.jpg | GRAPHIC | 163380
9 | GRAHPIC | vtvt-20240425_g4.jpg | GRAPHIC | 119019
10 | GRAHPIC | vtvt-20240425_g5.jpg | GRAPHIC | 112781
11 | GRAHPIC | vtvt-20240425_g6.jpg | GRAPHIC | 105282
12 | GRAHPIC | vtvt-20240425_g7.jpg | GRAPHIC | 1361116
13 | GRAHPIC | vtvt-20240425_g8.jpg | GRAPHIC | 466924
| Complete submission text file | 0001641489-24-000023.txt |  | 8762277

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vtvt-20240425.xsd | EX-101.SCH | 3031
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vtvt-20240425_def.xml | EX-101.DEF | 4282
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vtvt-20240425_lab.xml | EX-101.LAB | 4515
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vtvt-20240425_pre.xml | EX-101.PRE | 2993
25 | EXTRACTED XBRL INSTANCE DOCUMENT | vtvt-20240425_htm.xml | XML | 241472

Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37524 | Film No.: 24876713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)